{
  "id": "f174f827a8e8d4a0",
  "title": "STAT+: On Day 2 of JPM, Gilead lays outs it next test, a VC looks to raise funds, and one firm has FDA whiplash",
  "description": "Day 2 at #JPM26: You\u2019re back. We\u2019re sort of back. We\u2019re definitely not exhausted or delirious yet.",
  "content": "Day 2 at #JPM26: You\u2019re back. We\u2019re sort of back. We\u2019re definitely not exhausted or delirious yet.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/13/jpm-2026-day-2-top-stories-pazdur-travere-oz-pande/?utm_campaign=rss",
  "published_at": "2026-01-13T20:46:59+00:00",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: On Day 2 of JPM, Gilead lays outs it next test, a VC looks to raise funds, and one firm has FDA whiplash",
    "description": "Day 2 at #JPM26: You\u2019re back. We\u2019re sort of back. We\u2019re definitely not exhausted or delirious yet.",
    "url": "https://www.statnews.com/2026/01/13/jpm-2026-day-2-top-stories-pazdur-travere-oz-pande/?utm_campaign=rss",
    "published": "2026-01-13T20:46:59+00:00",
    "source": "STAT"
  }
}